Skip to main content
SpringerLink
Log in

Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer

  • Original Papers
  • Published:
Urological Research Aims and scope Submit manuscript

Abstract

Introduction: Determination of the risk of invasive bladder tumors progressing is still imprecise due to the heterogeneous biological behavior of this neoplasm. The goals of this study were to evaluate the patterns of expression of the epidermal growth factor (EGF) system in invasive bladder cancer and to assess its prognostic value.

Methods: This immunohistochemical study was performed using fresh frozen tumor samples and a panel of monoclonal antibodies on a series of 43 invasive bladder cancers treated by cystectomy.

Results: EGF was detected in 45% of the tumors and did not correlate with survival from bladder cancer. Transforming growth factor alpha (TGFα) was expressed by 60% of the tumors and correlated strongly with death from bladder cancer. Epidermal growth factor receptor (EGF-R) expression was seen in 86% of cases and had no prognostic significance. cerbB2 was expressed in 50% of cases and was inversely related to a poor prognosis. When EGF and TGFα were both expressed, there was little or no expression of c-erbB2.

Conclusion: The accumulation of several growth factors and the relevant receptor are necessary for the progression of invasive bladder cancers. They could be used as indicators of tumor aggressiveness.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bringuier PP, Umbas R, Schaafsma HE, Karthaus HFM, Debruyne FMJ, Schalken JA (1993) Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res 53:3241

    Google Scholar 

  2. Coombs LM, Oliver S, Sweeney E, Knowles M (1993) Immuno-cytochemical localization of c-erbB2 protein in transitional cell carcinoma of the urinary bladder. J Pathol 168:35

    Google Scholar 

  3. Cordon-Cardo C, Wartinger D, Petrylack D, Dalbagni G, Fair WF, Fuks Z, Renter VE (1992) Altered expression of retinobastoma protein and known prognostic variables in locally advanced bladder cancer. J Natl Cancer Inst 84:1256

    Google Scholar 

  4. DePotter CR, Beghin C, Makar AP, Vandekerchkhove D, Roels HJ (1990) The neurooncogene protein as a predictive factor for hematogenous metastases in breast cancer patients. Int J Cancer 45:55

    Google Scholar 

  5. DiMarco E, Pierce JH, Aaronson SA, DiFiore PP (1990) Mechanisms by which EGF receptor and TGF alpha contribute to malignant transformation. Nat Imm Cell Reg 9:209

    Google Scholar 

  6. Fradet Y (1990) Biological markers of prognosis in invasive bladder cancer. Semin Oncol 17:533

    Google Scholar 

  7. Fukuyama R, Shimizu N (1991) Expression of epidermal growth factor (EGF) and the EGF receptor in human tissues. J Exp Zool 258:336

    Google Scholar 

  8. Gates RE, King LE, Jr (1985) Different forms of the epidermal growth factor receptor kinase have different autophosphorylation sites. Biochemistry 24:5209

    Google Scholar 

  9. Gleave ME, Hsieh JT, Wu HC, Hong SJ, Zhau HE, Guthrie PD, Chung LWK (1993) Epidermal growth factor receptor-mediated autocrine and paracrine stimulation of human transitional cell carcinoma. Cancer Res 53:5300

    Google Scholar 

  10. Holmes WE, Sliwkowski MX, Akita RW, Henzel WJ, Lee J, Park JW, Yansura D, Abadi N, Raab H, Lewis GD (1992) Identification of heregulin, a specific activator of p185 erbB2. Science 256:1205

    Google Scholar 

  11. International Union Against Cancer (1987) TNM classification of malignant tumors, 4th edn. SpringerBerlin Heidelberg New York

    Google Scholar 

  12. Klijn JG, Berns PM, Schmitz PI, Foekens JA (1992) The clinical significance of epidermal growth factor receptor (EGF-R) in human breast cancer: A review of 5232 patients. Endocr Rev 13:3

    Google Scholar 

  13. Lau JLT, Fowler JE, Jr, Ghosh L (1988) Epidermal growth factor in the normal and neoplastic kidney and bladder. J Urol 139:170

    Google Scholar 

  14. Limas C (1991) Relationship of epidermal growth factor receptor deductibility with the A,B,H blood group antigens: Emphasis on normal and neoplastic urothelium. Am J Pathol 139:131

    Google Scholar 

  15. Limas C, Bair R, Bernhart P (1993) Reddy P proliferation activity of normal and neoplastic urothelium and its relation to epidermal growth factor and transferrin receptors. J Clin Pathol 46:810

    Google Scholar 

  16. Lipponen P (1993) Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value. Int J Cancer 53:365

    Google Scholar 

  17. Lipponen P (1993) Expression of c-erbB-2 oncoprotein in transitional cell bladder cancer. Eur J Cancer 29A:749

    Google Scholar 

  18. Marth C, Lang T, Cronauer MV, Doppler W, Zeimet AG, Bachmair F, Ullrich A, Dazembichler G (1992) Epidermal growth factor reduces HER-2 protein level in human ovarian carcinoma cells. Int J Cancer 52:311

    Google Scholar 

  19. McCann A, Dervan PA, Johnston PA, Gullick WJ, Carney DN (1990) c-erbB-2 oncoprotein expression in primary human tumors. Cancer 65:88

    Google Scholar 

  20. Messing EM (1990) Clinical implications of the expression of epidermal growth factor receptors in human transitional cell carcinoma. Cancer Res 50:2530

    Google Scholar 

  21. Messing EM, Reznikoff CA (1987) Normal and malignant human urothelium: In vitro effects of epidermal growth factor. Cancer Res 47:2230

    Google Scholar 

  22. Moriyama M, Akiyama T, Yamamoto T, Kawamoto T, Kato T, Sato K, Watanuki T, Hikage T, Katzuta N, Mori S (1991) Expression of c-erbB-2 gene product in urinary bladder cancer. J Urol 145:423

    Google Scholar 

  23. Mostofi FK, Sobin HL, Torlini H (1973) Histologic typing of urinary bladder tumors. World Health Organization, Geneva

    Google Scholar 

  24. Neal DE, Mellon K (1992) Epidermal growth factor receptor and bladder cancer: a review. Urol Int 48:365

    Google Scholar 

  25. Neal DE, Bennett MK, Hall RR, Marsh C, Abel P, Sainsbury JRC (1985) Epidermal growth factor receptors in human bladder cancer: Composition of invasive and superficial tumours. Lancet I:366

    Google Scholar 

  26. Neal DE, Sharples L, Smith K, Fennelly J, Hall RR, Harris AL (1990) The epidermal growth factor receptor and the prognosis of bladder cancer. Cancer 65:1619

    Google Scholar 

  27. Nguyen PL, Swanson PE, Jaszcz W, Aeppli DM, Zhang G, Singleton TP, Ward S, Dykoski D, Harvey J, Nichans GA (1994) Expression of epidermal growth factor receptor in invasive transitional cell carcinoma of the urinary bladder: a multivariate survival analysis. Am J Clin Pathol 101:166

    Google Scholar 

  28. Nickell KA, Halper J, Moses HL (1983) Transforming growth factors in solid human malignant neoplasms. Cancer Res 43:1966

    Google Scholar 

  29. Press MF, Hung G, Godolphin W, Slamon DJ (1994) Sensitivity of HER-2/neu antibodies in archival tissue samples: Potential source of error in immunohistochemical studies of oncogene expression. Cancer Res 54:2771

    Google Scholar 

  30. Sainsbury JRC, Malcom AJ, Appleton DR, Farndon JR, Harris AL (1985) Presence of EGF-R as an indicator of poor prognosis in patients with breast cancer. J Clin Pathol 38:1225

    Google Scholar 

  31. Sato K, Moriyama M, Mori S, Saito M, Watanuki T, Terada K, Okuhara E, Akiyama T, Toyoshima K, Yamamoto T, Kato T (1992) An immunohistologic evaluation of c-iterbB-2 gene product in patients with urinary bladder carcinoma. Cancer 70:2493

    Google Scholar 

  32. Sauter G, Haley J, Chew K, Kerschmann R, Moore D, Carroll P, Moch H, Gudat F, Mihatsch MJ (1994) Epidermal growth factor receptor expression is associated with rapid tumor proliferation in bladder cancer. Int J Cancer 57:508

    Google Scholar 

  33. Sherwin SA, Twardzik DR, Bohn WH, Cockley KD, Todaro GJ (1983) High molecular weight transforming growth factor activity in the urine of patients with disseminated cancer. Cancer Res 43:403

    Google Scholar 

  34. Swanson PE, Frierson HF, Jr, Wick MR (1992) c-erbB-2 (HER-2/neu) oncopeptide immunoreactivity in localized high grade transitional cell carcinoma of the bladder. Mod Pathol 5:531

    Google Scholar 

  35. Tribukait B, Gustafson H, Esposti PL (1982) The significance of ploidy and proliferation in the clinical and biological evaluation of bladder tumors: A study of 100 untreated cases. Br J Urol 54:130

    Google Scholar 

  36. Visscher DW, Castellani R, Wykes SM, Sarkar FH, Hussain ME (1993) Concurrent abnormal expression of ERBB-2, EGFR and p53 genes and clinical progression of breast carcinoma. Br Cancer Res Treat 28:261

    Google Scholar 

  37. Wood DP, Jr, Wartinger DD, Reuter V, Cordon-Cardo C, Fair WR, Chaganti SK (1991) DNA, RNA and immunohistochemical characterization of theHER-2/neu oncogene in transitional cell carcinoma of the bladder. J Urol 146:1398

    Google Scholar 

  38. Wright C, Mellon K, Johnston P, Lane DP, Harris AL, Horne CHW, Neal DE (1991) Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder. Br J Cancer 63:967

    Google Scholar 

  39. Wright C, Mellon K, Neal DE, Johnson P, Corbett IP, Horne CHW (1990) Expression of c-erbB-2 (neu) protein product in bladder cancer. Br J Cancer 62:764

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Service d'Urologie, Centre Hospitalier Universitaire Bichat, 46 Rue Henri Huchard, 75018, Paris, France

    V. Ravery

  2. Department of Pathology, Wagne State University and Harper Hospital, Detroit, Michigan, USA

    D. Grignon & J. Crissman

  3. Department of Urology, Wagne State University and Harper Hospital, Detroit, Michigan, USA

    J. Angulo, E. Pontes & J. Montie

  4. Groupe D'Etude des Tumeurs, Urologiques (GE.T.U.), F-94000, CHU Henri Mondor, Créteil, France

    D. Chopin

Authors
  1. V. Ravery
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. D. Grignon
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. Angulo
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. E. Pontes
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J. Montie
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. J. Crissman
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. D. Chopin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ravery, V., Grignon, D., Angulo, J. et al. Evaluation of epidermal growth factor receptor, transforming growth factor alpha, epidermal growth factor and c-erbB2 in the progression of invasive bladder cancer. Urol. Res. 25, 9–17 (1997). https://doi.org/10.1007/BF00941900

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00941900

Key words

Search

Navigation